Cromolyn sodium is effective in adult chronic asthmatics

The American Review of Respiratory Disease
T L PettyR Oakley

Abstract

We studied 68 chronic asthmatic patients, 18 to 76 yr of age, with a percent predicted FEV1 between 33 and 81, comparing cromolyn sodium with placebo. We used a double-blind, comparative group trial design. A 4-wk baseline period was followed by 3 months of active treatment or placebo. Patients recorded symptom severity and frequency of study drug and concomitant medication usage on daily diary cards. At each clinic visit, patients independently assessed the effectiveness of the test medication in controlling their asthma. Physicians also assessed the severity of the patients' symptoms, pulmonary function, and effectiveness of test medication at monthly intervals. Methacholine challenges were done pre- and post-treatment. Use of concomitant therapy was reduced according to a specified schedule. There was significant improvement in the severity of daytime asthma, nighttime asthma, and cough as assessed by the patients in the cromolyn sodium group. Mean use of concomitant medications decreased significantly in cromolyn sodium patients. Despite the reductions in the use of bronchodilators, pulmonary function (FEV1, FVC, FEF25-75) improved significantly in the cromolyn sodium group. Similar improvements did not occur in the control...Continue Reading

Citations

Jan 5, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·M Frieri
Feb 1, 1996·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·J BousquetJ Bons
Jan 1, 1994·Mediators of Inflammation·E A Valletta, A L Boner
Jun 4, 2010·The Clinical Respiratory Journal·Christer Janson
Nov 3, 1998·The Journal of Allergy and Clinical Immunology·S J Szefler, H S Nelson
Aug 13, 2005·Respiratory Medicine·Yasuyuki SanoTerumasa Miyamoto
Jun 1, 1996·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·K H Carlsen, K Larsson
May 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H MagnussenD Nowak
Jul 1, 1994·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A M Edwards
Nov 30, 1989·The New England Journal of Medicine·P J Barnes
Jan 1, 1990·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·G F MacDonald
Jan 1, 1990·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·W W Busse
Mar 1, 1991·Disease-a-month : DM·R B George, M W Owens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.